16 Dementia Types, Symptoms, & Stages The Dementia Types, Risk Fa, Symptoms, Diagnosis, Treatment, Stages, and Prevention Series focuses on all 16 primary dementias: Alzheimer's disease Vascular dementia: Buerger's disease Intestinal ischemic syndrome Peripheral artery disease Popliteal entrapment syndrome Raynaud's phenomenon Renal artery disease Lewy Body dementias: Dementia with Lewy bodies/DLB Parkinson's disease dementia/PDD LATE (Limbic-predominant age-related TDP-43 encephalopathy) Normal Pressure Hydrocephalus Frontotemporal Dementia (FTD): Behavioral Variant FTD (bvFTD) Primary Progressive Aphasia (PPA) Creutzfeldt-Jacob Disease Wernicke-Korsakoff Syndrome Huntington's Disease This book breaks the medical terms down to common language where possible, describes each specific dementia and teaches the basics of this terrifying disease. The cause of death for one out of every six people, dementia strikes one of three seniors. Book 1 in the series, Dementia Types, Symptoms, & Stages borrows from each book in the series and explains: What each dementia is Each dementia's stages Each dementia's symptoms Like the series, the book is organic and grows with the series. This book began years ago as a 50-page guide and has inspired two entire series. This book is now over 400 pages. Beller Health Research Institute updates this book and series several times per year, including significant annual updates.

DEMENTIA TYPES, SYMPTOMS, & RISK FACTORSGet the best science in everyday language. We cover: Dementia with Lewy Bodies - Parkinson's disease dementia - Corticobasal Syndrome - Posterior Cortical Atrophy - Down Syndrome with Alzheimer's - Early-onset Alzheimer's Disease - Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)Behavioral variant frontotemporal dementia (bvFTD) - Progressive Supranuclear Palsy - Nonfluent Variant Primary Progressive Aphasia -Logopenic Progressive Aphasia - Cortical Vascular Dementia - Binswanger Disease - Huntington's Disease - Normal Pressure Hydrocephalus - Wernicke-Korsakoff Syndrome - Amyotrophic Lateral Sclerosis - Creutzfeldt-Jakob Disease Scroll Up to Get Your Copy

DEMENTIA Types, Risk Factors, & Symptoms The 2020 edition updates the first book to cover all 19 primary dementia types. We add new science from the past year and polish the previous edition. This book defines each of the 19 primary dementia types and examines symptoms and risk factors. Lewy body dementia1. Dementia with Lewy bodies/DLB 2. Parkinson's disease dementia/PDD Frontotemporal dementia (FTD)3. Behavioral Variant Frontotemporal Dementia(bvFTD)4. Primary Progressive Aphasia (PPA)Vascular Dementias5. Post-stroke dementia6. Multi-infarct dementia7. Subcortical vascular dementiaOther Dementias8. Alzheimer's disease9. Posterior Cortical Atrophy (PCA)10. DownSyndrome and Alzheimer's Disease11. Normal-pressurehydrocephalus12. Creutzfeldt-Jacobdisease13. Huntington'sdisease14. LATE(the newest dementia category)15. KorsakoffSyndrome 16. amyotrophiclateral sclerosis 17. HIV-RelatedCognitive Impairment 18. ChronicTraumatic Encephalopathy 19. CorticobasalSyndrome 20. ProgressiveSupranuclear Palsy Stroll Up to Download Your Copy!

Up-to-date discussion of the etiology, diagnosis, treatment, and prevention of this common cause of stroke and cognitive impairment.

New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.

As the largest generation in U.S. history - the population born in the two decades immediately following World War II - enters the age of risk for cognitive impairment, growing numbers of people will experience dementia (including Alzheimer's disease and related dementias). By one estimate, nearly 14 million people in the United States will be living with dementia by 2060. Like other hardships, the experience of living with dementia can bring unexpected moments of intimacy, growth, and compassion, but these diseases also affect people's capacity to work and carry out other activities and alter their relationships with loved ones, friends, and coworkers. Those who live with and care for individuals experiencing these diseases face challenges that include physical and emotional stress, difficult changes and losses in their relationships with life partners, loss of income, and interrupted connections to other activities and friends. From a societal perspective, these diseases place substantial demands on communities and on the institutions and government entities that support people living with dementia and their families, including the health care system, the providers of direct care, and others. Nevertheless, research in the social and behavioral sciences points to possibilities for preventing or slowing the development of dementia and for substantially reducing its social and economic impacts. At the request of the National Institute on Aging of the U.S. Department of Health and Human Services, Reducing the Impact of Dementia in America assesses the contributions of research in the social and behavioral sciences and identifies a research agenda for the coming decade. This report offers a blueprint for the next decade of behavioral and social science research to reduce the negative impact of dementia for America's diverse population. Reducing the Impact of Dementia in America calls for research that addresses the causes and solutions for disparities in both developing dementia and receiving adequate treatment and support. It calls for research that sets goals meaningful not just for scientists but for people living with dementia and those who support them as well. By 2030, an estimated 8.5 million Americans will have Alzheimer's disease and many more will have other forms of dementia. Through identifying priorities social and behavioral science research and recommending ways in which they can be pursued in a coordinated fashion, Reducing the Impact of Dementia in America will help produce research that improves the lives of all those affected by dementia.

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology. Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinology Includes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications